- Home
- FOLD vs GPI Comparison
FOLD vs GPI Comparison
Compare FOLD & GPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | GPI |
|---|---|---|
| Founded | 2002 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2006 | 1997 |
Fundamental Metrics
Financial Performance| Metric | FOLD | GPI |
|---|---|---|
| Price | $14.46 | $337.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $27.25 | ★ $442.63 |
| AVG Volume (30 Days) | ★ 2.6M | 146.7K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 25.24 |
| Revenue | N/A | ★ $11,123,721,000.00 |
| Revenue This Year | $20.50 | $3.64 |
| Revenue Next Year | $18.59 | $3.08 |
| P/E Ratio | ★ N/A | $13.37 |
| Revenue Growth | N/A | ★ 2.17 |
| 52 Week Low | $5.66 | $292.44 |
| 52 Week High | $14.48 | $488.39 |
Technical Indicators
Market Signals| Indicator | FOLD | GPI |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 58.48 |
| Support Level | $14.21 | $324.49 |
| Resistance Level | N/A | $347.81 |
| Average True Range (ATR) | 0.02 | 10.01 |
| MACD | -0.01 | 2.37 |
| Stochastic Oscillator | 75.00 | 63.23 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About GPI Group 1 Automotive Inc.
Group 1 owns and operates 32 collision centers and 254 automotive dealerships in the US and the UK, offering 36 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 31.6% of new-vehicle unit volume in 2025 and the UK 27.6%. Texas, Massachusetts, and California combined was 45.4%. Revenue in 2025 totaled $22.6 billion. The firm entered the UK in 2007 and has 109 stores there contributing about 26% of total revenue. Group 1 was founded in 1995 and is based in Houston.